Efimosfermin alfa Clinical Trials

4 actively recruiting trials across 2 locations

No change since May 2026

Pipeline

Phase 1: 2Phase 3: 2

Top Sponsors

GlaxoSmithKline4

Indications

Liver Disease4
Non Alcoholic Fatty Liver Disease4

Arcadia, California2 trials

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

GSK Investigational Site

Phase 3

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

GSK Investigational Site

Phase 3

Other1 trial

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Efimosfermin Alfa Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and White/European Ancestry

Phase 1

Rialto, California1 trial

A Study of Efimosfermin Alfa in Adults With Hepatic Impairment

GSK Investigational Site

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.